HC Wainwright Adjusts Price Target on Vir Biotechnology to $100 From $125, Keeps Buy Rating - Marketscreener.com

HC Wainwright Adjusts Price Target on Vir Biotechnology to $100 From $125, Keeps Buy Rating  Marketscreener.com